Literature DB >> 12492711

Improved islet yields from Macaca nemestrina and marginal human pancreata after two-layer method preservation and endogenous trypsin inhibition.

Shinichi Matsumoto1, Theodore H Rigley, Jo Anna Reems, Yoshikazu Kuroda, R Brian Stevens.   

Abstract

We tested whether two-layer method (TLM) pancreas preservation and trypsin inhibition (Pefabloc) during processing allows longer preservation while retaining or improving viable islet recovery. Non-marginal primate (Macaca nemestrina) and marginal human (ischemic or preservation-injured) pancreata were processed with a research-oriented pan technique (Seattle method). Organs were processed upon arrival (+/- Pefabloc), or after TLM or University of Wisconsin solution (UW) preservation (+ Pefabloc). Islet yield, viability, and function were assessed. Pefabloc increased M. nemestrina islet yields from 9696 +/- 1749 IE/g to 15 822 +/- 1332 IE/g (p < 0.01). Two-layer method preservation (< 6 h) further increased yields, to 23 769 +/- 2773 IE/g (vs. + Pefabloc; p < 0.01). Similarly, Pefabloc increased marginal human islet yields from 2473 +/- 472 IE/g to 4723 +/- 1006 IE/g (p < 0.04). This increase was maintained after lengthy TLM preservation (> 30 h; 4801 +/- 1066 IE/g). We also tested the applicability of TLM preservation (23.5 +/- 3.2 h) to the processing of marginal human pancreata by the Edmonton/Immune Tolerance Network clinical protocol. Islet yield and function approached published results of pancreata processed 4.8 +/- 0.8 h after organ recovery (p = 0.06). Pefabloc, and TLM vs. UW preservation, prolonged the tolerable interval between organ recovery and islet isolation. Islet yield, viability, and functionality improved from both marginal and nonmarginal pancreata.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12492711     DOI: 10.1034/j.1600-6143.2003.30110.x

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  6 in total

1.  Limitations in the Use of Fluorescein Diacetate/Propidium Iodide (FDA/PI) and Cell Permeable Nucleic Acid Stains for Viability Measurements of Isolated Islets of Langerhans.

Authors:  Vinc Boyd; Olivia Maria Cholewa; Klearchos K Papas
Journal:  Curr Trends Biotechnol Pharm       Date:  2008-03

2.  Insulin degradation by acinar cell proteases creates a dysfunctional environment for human islets before/after transplantation: benefits of α-1 antitrypsin treatment.

Authors:  Gopalakrishnan Loganathan; Rajinder K Dawra; Subbiah Pugazhenthi; Zhiguang Guo; Sajjad M Soltani; Alexander Wiseman; Mark A Sanders; Klearchos K Papas; Kumaravel Velayutham; Ashok K Saluja; David E R Sutherland; Bernhard J Hering; A N Balamurugan
Journal:  Transplantation       Date:  2011-12-15       Impact factor: 4.939

3.  Improvement of pancreatic islet cell isolation for transplantation.

Authors:  Shinichi Matsumoto; Hirofumi Noguchi; Bashoo Naziruddin; Nicolas Onaca; Andrew Jackson; Hatanaka Nobuyo; Okitsu Teru; Kobayashi Naoya; Göran Klintmalm; Marlon Levy
Journal:  Proc (Bayl Univ Med Cent)       Date:  2007-10

4.  Clinical allogeneic and autologous islet cell transplantation: update.

Authors:  Shinichi Matsumoto
Journal:  Diabetes Metab J       Date:  2011-06-30       Impact factor: 5.376

5.  Implication of mitochondrial cytoprotection in human islet isolation and transplantation.

Authors:  Yong Wang; Joshua E Mendoza-Elias; Meirigeng Qi; Tricia A Harvat; Sang Joon Ahn; Dongyoung Lee; Diana Gutierrez; Hyojin Jeon; Daniel Paushter; José Oberholzer
Journal:  Biochem Res Int       Date:  2012-05-07

Review 6.  The History of Clinical Islet Transplantation in Japan.

Authors:  Taihei Ito; Takashi Kenmochi; Kei Kurihara; Naohiro Aida
Journal:  J Clin Med       Date:  2022-03-16       Impact factor: 4.241

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.